Close

Log In

 

Exploring RE-CIRCUIT

Join Dr Hugh Calkins for a discussion of his groundbreaking paper: Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.

Topic

Catheter ablation is an antiarrhythmic surgical technique used in the treatment of atrial fibrillation. Typically, it is performed with uninterrupted anticoagulation with warfarin, or interruption of a NOAC course for a period before and following surgery. However, the results of this new study indicate that an uninterrupted course of NOACs may, in fact, be safer than other anticoagulant courses.

Target audience

This educational activity is designed for cardiologists, surgeons, primary care physicians, GPs, nurses and any other healthcare professional with an interest or role in atrial fibrillation management.

Learning objective

Upon completion of this activity, participants should be able to:

  • Identify factors that influence the choice and dose of oral anticoagulant in atrial fibrillation patients scheduled to receive an ablation procedure

Funding

This independent educational activity by NOAC Education is supported by funding from Boehringer Ingelheim. PCM Scientific is the medical education company acting as scientific secretariat and organiser for this programme. The activity is run at arm’s length from the financial supporter and all content is created by the faculty. No funder has had input into the content of the activity.

Faculty

John Camm
St George’s, University of London
Professor of Clinical Cardiology at St. George's Hospital Medical School in London
Hugh Calkins
John Hopkins Hospital
Dr Hugh Calkins is the Nicholas J. Fortuin M.D. Professor of Cardiology and Professor of Medicine at the Johns Hopkins University School of Medicine.